Suzuki Masataka

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Suzuki Masataka and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Suzuki

Suzuki Masataka

Assistant Professor

Baylor College of Medicine

I have extensive experience with adenoviral gene therapy for genetic disorders and cancer, as well as a broad background in the development of gene therapy vectors, with specific training and expertise in key research areas relevant to cancer immunotherapy. Since local treatment of oncolytic adeno-immunotherapy remains insufficient to create complete responses to metastatic tumors, my group has been working on combination of oncolytic adenovirus with CAR T-cells, that home to both primary and metastatic tumors, overcoming the limited systemic anti-tumor effects of locally administered adenovirus-based cancer immunotherapies.

Talks About
#immunology #drugdiscovery

Preferred Locations
#NorthAmerica

Speaking Engagements

Advances in CAR T Therapy

Paid

Cell therapies such as CAR Ts are now a proven treatment approach for hematological cancers, but challenges remain around CAR T’s ability to target solid tumors. Cambridge Healthtech Institute’s Tenth Annual Advances in CAR T Therapy conference brings together leading researchers and companies to discuss the latest developments in CAR T and CAR-ena

07-08 August 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Suzuki Masataka

Assistant Professor

Speaking Engagements

Advances in CAR T Therapy